E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/22/2015 in the Prospect News Bank Loan Daily, Prospect News Distressed Debt Daily and Prospect News High Yield Daily.

S&P upgrades Venoco

Standard & Poor’s said it raised the corporate credit rating on Venoco Inc. to CCC+ from SD (selective default), along with the ratings on its senior unsecured notes to CCC- from D.

The recovery rating on these notes remains at 6, reflecting 0 to 10% expected default recovery.

The outlook is negative.

The agency also said it affirmed the ratings on parent company Denver Parent Corp., including its CCC+ corporate credit rating and CCC- unsecured issue-rating. The ratings also were removed from CreditWatch, where they were placed with negative implications April 3, S&P said.

The outlook on Denver Parent was revised to negative from stable.

The upgrades follow a review of Venoco’s credit profile in conjunction with the release of its year-end 2014 financial results, the agency said, and the completion of the exchange of its senior unsecured notes whereby existing investors received new second-lien notes at 77˝% of par value.

The exchange is viewed as tantamount to default because investors received less than the promise of the original securities, S&P said.

Concurrent with the exchange, Venoco issued $175 million of first-lien notes and entered into $75 million of cash-secured senior term loans. The company’s senior secured credit facility was subsequently terminated.

The recovery rating of 6 on Venoco’s senior unsecured notes considers the increase in secured debt ahead of the notes in the capital structure, the agency said.

With the issuance of the first-lien notes and cash-secured term loan, the company has an improved liquidity, which is now considered adequate, S&P said.

The agency said it expects sources will exceed uses by more than 1.2x at least over the next 12 months even if EBITDA declines by 15%.

The outlook is negative, reflecting a view that Venoco might pursue additional debt exchanges in which investors receive less than what was promised on the original securities, S&P said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.